STABLE PROTEIN AND NUCLEIC ACID FORMULATIONS, USING NON-AQUEUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY

THIS INVENTION RELATES TO STABLE NON-AQUEOUS FORMULATIONS WHICH ARE SUSPENSIONS OF PROTEINACEOUS SUBSTANCES OR NUCLEIC ACIDS IN NON-AQUEOUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY. MORE SPECIFICALLY , THE PRESENT INVENTION RELATES TO STABLE PROTEIN OR NUCLEIC ACID FO...

Full description

Saved in:
Bibliographic Details
Main Authors JESSICA G. SMITH, MANLEY T.F. HUANG, STEVEN J. PRESTRELSKI, VICTORIA MARIE KNEPP
Format Patent
LanguageEnglish
Published 30.08.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:THIS INVENTION RELATES TO STABLE NON-AQUEOUS FORMULATIONS WHICH ARE SUSPENSIONS OF PROTEINACEOUS SUBSTANCES OR NUCLEIC ACIDS IN NON-AQUEOUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY. MORE SPECIFICALLY , THE PRESENT INVENTION RELATES TO STABLE PROTEIN OR NUCLEIC ACID FORMULATIONS WHEREIN THE COMPOUND REMAINS INSTABLE, DRY POWDER FORM, YET THE FORMULATION IS FLOWABLE AND, THEREFORE AMENABLE TO DELIVERY TO AN ANIMAL VIA INJECTION, TRANSDERMAL ADMINISTRATION, ORAL DELIVERY OR USING AN IMPLANTABLE DEVICE FOR SUSTAINED DELIVERY. THESE STABLE FORMULATIONS MAY BE STORED AT ELEVATED TEMPERATURES (E.G., 37°C ) FOR LONG PERIODS OF TIME AND ARE ESPECIALLY USEFUL AS FLOWABLE FORMULATIONS WHICH CAN BE SHIPPED AND/OR STORED AT HIGH TEMPERATURES OR IN IMPLANTABLE DELIVERY DEVICES FOR LONG TERM DELIVERY (E.G., 1-12 MONTHS OR LONGER) OF DRUG.
Bibliography:Application Number: MY1997PI04817